Germany Rethinks Cannabis

Germany’s cannabis debate is changing again. After partially legalising cannabis in 2024, the country is now facing a new question: how should cannabis be managed in the real world?

The latest shift comes from Hendrik Streeck, Germany’s Federal Drug Commissioner. Streeck is a member of the CDU, a party that has often criticised cannabis reform. That makes his recent comments especially interesting. Instead of calling only for a rollback of the law, he has said he is open to controlled cannabis pilot projects.

These pilots would not mean open cannabis shops across Germany. They would be limited trials, carefully monitored by researchers, with strict rules on who can buy cannabis, how much they can buy, and how the system is controlled.

In other words, Germany is not rushing into a commercial cannabis market. But it may be starting to rethink what effective cannabis policy should look like.

A Law That Changed the Debate

Germany’s Cannabis Act came into force on 1 April 2024. It allowed adults to possess limited amounts of cannabis, grow up to three plants at home, and join non-profit cannabis cultivation associations.

This was a major moment for cannabis policy in Europe. Germany became one of the largest countries on the continent to move away from full prohibition. But the law did not create a normal retail cannabis market. There are no nationwide recreational cannabis shops, and legal access remains limited.

That has left Germany in an unusual position. Cannabis is partly legal, but legal supply is still restricted. For many people, the black market has not disappeared. For lawmakers, this has created a difficult challenge: if adults are allowed to use cannabis, where should they legally get it from?

Why Pilot Projects Are Being Discussed

Pilot projects are designed to test cannabis sales under strict conditions. They allow policymakers to collect evidence before making bigger decisions.

Streeck has suggested that any pilots should be cautious and tightly controlled. He has spoken about possible limits such as no advertising, no commercial expansion, no sales to younger adults, and only small purchase amounts. The idea is not to encourage cannabis use, but to see whether a regulated system can work better than the illegal market.

This is where the debate becomes more practical. Prohibition aims to stop cannabis use, but millions of adults in Germany already use cannabis. A pilot project accepts that reality and asks a different question: can the state control cannabis better through regulation than through punishment?

A Conservative Shift

Streeck’s position stands out because it differs from the harder line often associated with the CDU. Some conservative politicians have argued that Germany’s cannabis law should be reversed. They worry about youth access, public health, road safety, and the normalisation of cannabis.

Streeck has not dismissed those concerns. His approach is still cautious. But he seems to recognise that simply reversing the law may not solve the problem.

That is why his comments matter. They suggest that even within more conservative circles, cannabis policy may be moving away from slogans and towards evidence. Instead of asking only whether cannabis is good or bad, Germany is beginning to ask what kind of system gives society the most control.

The Medical Cannabis Question

Another part of the debate is medical cannabis. Since Germany changed its cannabis laws, access to medical cannabis has become easier, especially through online services.

This has raised concerns that some people may be using medical cannabis routes for non-medical reasons. Streeck has warned that medical cannabis and recreational cannabis should remain clearly separated. If the medical system is used as a backdoor for recreational access, it could damage trust in genuine cannabis treatment.

This is another reason pilot projects may be useful. A controlled adult-use trial could help separate recreational demand from medical need. Patients who rely on cannabis as medicine should not be mixed into the same debate as adults who want to use cannabis recreationally.

Cannabis Clubs and Real-World Access

Germany’s cannabis cultivation associations, often called cannabis clubs, were supposed to provide a legal route for adults. These clubs are non-profit and heavily regulated. Members can receive cannabis grown by the association, but the system has been slow and complicated.

If legal access is too difficult, people may simply continue using illegal sources. That creates problems for product safety, age checks, and public health monitoring.

This is one of the central challenges of cannabis reform. A legal system only works if people can realistically use it. If the rules are too strict, too slow, or too confusing, the black market remains attractive.

Regulation Is Not the Same as Promotion

One of the biggest misunderstandings in cannabis debates is the idea that regulation means encouragement. It does not.

A regulated cannabis system can include strict age limits, product controls, health information, purchase limits, and bans on advertising. These tools are almost impossible to apply properly in an illegal market.

For Germany, the question is not whether cannabis carries risks. It does. The question is whether those risks are better handled through prohibition or through controlled access.

Pilot projects could help answer that question with real data instead of political guesswork.

Germany in a European Context

Germany is not alone in exploring new cannabis models. The Netherlands has been testing regulated cannabis supply through its own experiment, and Switzerland has allowed local cannabis pilot trials.

These projects are being watched closely across Europe. Cannabis reform in Europe tends to move slowly, often through experiments rather than sudden nationwide change. Germany’s size and influence make its decisions especially important.

If Germany moves forward with cannabis pilot projects, the results could shape future debates far beyond its own borders.

A New Phase in Cannabis History

For the Cannabis Museum, this moment is part of a much longer story. Cannabis policy has always moved through cycles of fear, control, resistance, medical interest, and reform. Germany’s current debate shows how complicated that history still is.

The country has already taken a major step by partially legalising cannabis. Now it is trying to decide what comes next. Should the law be tightened, expanded, reversed, or tested more carefully?

Streeck’s comments do not mean Germany is about to fully legalise commercial cannabis sales. But they do show that the debate is becoming more realistic. Even some critics of cannabis reform now appear willing to consider controlled experiments.

That is why the title Germany Rethinks Cannabis fits the moment. This is not simply a story about legalisation. It is a story about a country trying to understand what works.

Cannabis has not disappeared from German society. The real question is who controls it: illegal markets, medical loopholes, non-profit clubs, or a carefully regulated system.

Germany has not answered that question yet. But it is clearly beginning to ask it in a new way.